Naltrexone is an opioid antagonist used to manage alcohol dependence and prevent relapse in patients with opioid use disorder by effectively blocking mu-opioid receptors. Laboratories require a comprehensive… Read more
![Chemical structure of (3R,4R,4aS,6aR,11bS)-6-Carboxy-3-(cyclopropylmethyl)-4a,6,8-trihydroxy-3-methyl-1,2,3,4,4a,5,6,6a-octahydro-4,11-methanobenzofuro[3',2':2,3]cyclopenta[1,2-c]pyridin-3-ium Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3R4R4aS6aR11bS-6-Carboxy-3-cyclopropylmethyl-4a68-trihydroxy-3-methyl-12344a566a-octahydro-411-methanobenzofuro3223cyclopenta12-cpyridin-3-ium-Bromide.png&w=3840&q=75)
![Chemical structure of (3R,4R,4aS,7aR,12bS)-3-(Cyclopropylmethyl)-4a,6,6,9-tetrahydroxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3R4R4aS7aR12bS-3-Cyclopropylmethyl-4a669-tetrahydroxy-3-methyl-7-oxo-2344a5677a-octahydro-1H-412-methanobenzofuro32-eisoquinolin-3-ium-bromide.png&w=3840&q=75)
![Chemical structure of (3S,4R,4aS,7aR,12bS)-9-Acetoxy-3-(cyclopropylmethyl)-4a-hydroxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1252784-80-7-3S4R4aS7aR12bS-9-Acetoxy-3-cyclopropylmethyl-4a-hydroxy-3-methyl-7-oxo-2344a5677a-octahydro-1H-412-methanobenzofuro32-eisoquinolin-3-ium-.png&w=3840&q=75)

![Chemical structure of (4R,4aS,11bS)-3-(Cyclopropylmethyl)-4a,6,8-trihydroxy-1,2,3,4,4a,5,6,6a-octahydro-4,11-methanobenzofuro[3',2':2,3]cyclopenta[1,2-c]pyridine-6-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS11bS-3-Cyclopropylmethyl-4a68-trihydroxy-12344a566a-octahydro-411-methanobenzofuro3223cyclopenta12-cpyridine-6-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7aR,12bS)-2,3,4,4a,5,6,7,7a-Octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1649937-51-8-4R4aS7aR12bS-2344a5677a-Octahydro-1H-412-methanobenzofuro32-eisoquinoline-4a79-triol.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7aR,12bS)-3-(Cyclopropylmethyl)-4a,9,13-trihydroxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS7aR12bS-3-Cyclopropylmethyl-4a913-trihydroxy-3-methyl-7-oxo-2344a5677a-octahydro-1H-412-methanobenzofuro32-eisoquinolin-3-ium-Bromide.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7aR,12bS)-3-(Cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F123086-68-0-4R4aS7aR12bS-3-Cyclopropylmethyl-4a9-dihydroxy-2344a-tetrahydro-1H-412-methanobenzofuro32-eisoquinolin-77aH-one.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7aR,12bS)-3-(Cyclopropylmethyl)-4a-hydroxy-9-methoxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1005410-37-6-4R4aS7aR12bS-3-Cyclopropylmethyl-4a-hydroxy-9-methoxy-3-methyl-7-oxo-2344a5677a-octahydro-1H-412-methanobenzofuro32-eisoquinolin-3-ium-Br.png&w=3840&q=75)
![Chemical structure of (4R,4aS,7aR,12bS)-3-Butyl-4a,9-dihydroxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4R4aS7aR12bS-3-Butyl-4a9-dihydroxy-3-methyl-7-oxo-2344a5677a-octahydro-1H-412-methanobenzofuro32-eisoquinolin-3-ium-Bromide.png&w=3840&q=75)
![Chemical structure of (4S,4aS,7aR,12bS)-3-(Cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-7,13-dioxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4S4aS7aR12bS-3-Cyclopropylmethyl-4a9-dihydroxy-3-methyl-713-dioxo-2344a5677a-octahydro-1H-412-methanobenzofuro32-eisoquinolin-3-ium-Bromide.png&w=3840&q=75)
![Chemical structure of (S)-N-(Cyclopropylmethyl)-2-((3aR,3a1S,9aR)-5,9a-dihydroxy-3-oxo-1,3,3a,9a-tetrahydrophenanthro[4,5-bcd]furan-3a1(2H)-yl)-N-methylethan-1-aminium Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-Cyclopropylmethyl-2-3aR3a1S9aR-59a-dihydroxy-3-oxo-133a9a-tetrahydrophenanthro45-bcdfuran-3a12H-yl-N-methylethan-1-aminium-Bromide.png&w=3840&q=75)



![Chemical structure of 2',3'-Dihydro-1'H,4a'H,7a'H-spiro[[1,3]dioxane-2,7'-[4,12](metheno)benzofuro[3,2-e]isoquinoline]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F595-98-2-23-Dihydro-1H4aH7aH-spiro13dioxane-27-412methenobenzofuro32-eisoquinoline.png&w=3840&q=75)

































Naltrexone is an opioid antagonist used to manage alcohol dependence and prevent relapse in patients with opioid use disorder by effectively blocking mu-opioid receptors. Laboratories require a comprehensive suite of high-quality reference standards to ensure the safety, efficacy, and regulatory compliance of this medication. This category includes the active pharmaceutical ingredient alongside a broad range of related compounds, including pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, degradation products, and specific hydroxy metabolites. These materials are essential for robust impurity profiling, method validation, and stability testing. Additionally, stable isotope labelled compounds are available to support precise quantitative analysis and mass balance studies during quality control processes. By utilizing these characterized standards, researchers and analytical chemists can maintain rigorous control over drug purity and performance throughout the product lifecycle.